SOURCE: Stock Market Alerts

October 10, 2006 09:40 ET

Stocks on the Move for Tuesday! October 10, 2006

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Stock Market Alerts.

MIAMI, FL -- (MARKET WIRE) -- October 10, 2006 -- Stock Market Alerts' performance stock list includes: Human Biosystems (OTCBB: HBSC), New River Pharmaceuticals Inc (NASDAQ: NRPH), Xilinx, Inc. (NASDAQ: XLNX), Peabody Energy (NYSE: BTU).

Once again, Human Biosystems (OTCBB: HBSC) is headed in a direction that should appeal to speculative investors this morning. Yesterday, after the stock markets closed, the company issued a press release announcing that HBS BioEnergy ("HBS Bio"), a wholly owned subsidiary of HBS, has appointed Mr. Claude Luster III as HBS BioEnergy's President.

This news could get the attention of investors. Mr. Luster, the founder of EXL III Group Corporation (EXL III), has been involved in the final stages of developing and funding a 60 million-gallon Northern California ethanol facility that he will complete while assuming his new duties with HBS BioEnergy.

"Among Mr. Luster's first duties will be to develop necessary strategic partners and consulting firms that HBS BioEnergy will need for the initial stages of production," stated Harry Masuda, CEO of Human BioSystems. "We are pleased to have Claude as our President. He has the technical and management background and the essential skills that HBS has been seeking," Mr. Masuda continued.

Mr. Luster was instrumental with EXL III's current plans to develop up to 10 renewable fuels plants and 10 value added bioconversion facilities. EXL III is also developing several new cost reduction processes for the production of ethanol and biodiesel.

This continues to be a stock for speculative investors to watch. "I see HBS Bio as an innovative company, prepared to join the burgeoning group of professionals who keep abreast of the ever-shifting trends in energy and environmental markets and who are constantly working to provide optimal solutions for the consumer. I'm pleased to be appointed to the position of President and look forward to a strong future with HBS Bio," stated Claude Luster III, President of HBS BioEnergy.

Human BioSystems main focus has been as a developer of preservation platforms for organs and other biomaterials. HBS is headquartered in Palo Alto, California with research facilities in Michigan.

On August 22nd, the company announced that it had formed HBS BioEnergy for the purpose of developing the bio energy business. The company stated that it made the decision to enter the bio energy field because it gives HBS the potential to achieve substantial revenue and profit growth within a predictable timetable and that the acquisition should give HBS additional financing options not previously available. The REAL story is in Human BioSystems' four patents for technologies that preserve platelets, a blood component used by chemotherapy, trauma, and other patients to stop bleeding and organs such as the kidney, heart, liver, and lung.

Prior to the news being released, the stock closed yesterday at Fourteen cents per share.

A profile of Human BioSystems can be found here: http://www.wallstreettradingalerts.com/HBSC100906.html.

Other Stocks of interest yesterday were:

New River Pharmaceuticals Inc (NASDAQ: NRPH) up 61.4% on 11.8 million
shares traded. New River
Pharmaceuticals Inc. is a specialty pharmaceutical company.

Xilinx, Inc. (NASDAQ: XLNX) up 2.5% on 7.4 million shares traded.
Xilinx, Inc. is the worldwide leader of programmable logic solutions.

Peabody Energy (NYSE: BTU) down 2% on 4.7 million shares traded.
Peabody Energy is the world's largest private-sector coal company.
Wall Street Enews is a Sponsor of Quality Stocks. Quality Stocks tracks the stock picks of 150 Investment Newsletters every day and reports on their performance. For Their Free Service, Visit www.qualitystocks.net.

The advertisement is provided by Wall Street Enews, a division of Stock Market Alerts LLC, an electronic broadcaster and publisher of this release, and hereafter referred to as "the company." The company received compensation for services performed for Human Biosystems (OTCBB: HBSC). The compensation is fourteen thousand dollars from the company. Because the company received compensation for its services, there is an inherent conflict of interest in the company statements and opinions and such statements and opinions cannot be considered independent.

The information contained in this press release is for informational purposes only, and not to be construed as an offer to sell or solicitation of an offer to buy any security. The company makes no representation or warranty relating to the validity of the facts presented nor does the company represent or warrant that all material facts necessary to make an investment decision are presented above. Stock Market Alerts LLC is an advertising company and therefore, this release should be viewed for informational purposes only.

The company relies exclusively on information gathered on the public company, such as public filings, press releases and its web sites. Investors should use the advertising information contained in this release as a starting point for conducting additional research on the public company in order to allow the investor to form his or her own opinion regarding the public company. Factual statements contained in this publication are made as of the date stated and they are subject to change without notice. The company is not a registered investment adviser, broker or a dealer.

Investing in the public company that this release is providing service for should be reviewed as speculative and a high-risk and may result in the loss of some or all of any investment.

This release may contain statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended. The words "may," "would," "will," "expect," "estimate," "anticipate," "believe," "intend," and similar expressions and variations thereof are intended to identify forward-looking statements.

Contact Information